BRIEF published on 11/26/2025 at 15:21, 11 months 26 days ago The Vanguard Group Discloses Stake in Mural Oncology plc Vanguard Group Stake Disclosure Investment Transparency Irish Takeover Rules Mural Oncology
BRIEF published on 11/26/2025 at 15:21, 11 months 26 days ago Le groupe Vanguard révèle sa participation dans Mural Oncology plc Groupe Vanguard Déclaration De Participation Transparence Des Investissements Oncologie Murale Règles Irlandaises En Matière De Rachat D'entreprises
BRIEF published on 11/26/2025 at 15:20, 11 months 26 days ago China Cycle 2026: Innovation and Intelligence in Focus Innovation Market Expansion Global Collaboration Bicycle Industry China Cycle 2026
BRIEF published on 11/26/2025 at 15:20, 11 months 26 days ago Cycle Chine 2026 : Innovation et intelligence au centre des préoccupations Innovation Collaboration Mondiale Expansion Du Marché Industrie Du Vélo Cycle Chine 2026
BRIEF published on 11/26/2025 at 15:20, 11 months 26 days ago The Vanguard Group's Stake in Greencore Group plc Disclosed Vanguard Group Share Disclosure Financial Investment UK Takeover Code Greencore Group
BRIEF published on 11/26/2025 at 15:20, 11 months 26 days ago La participation du groupe Vanguard dans Greencore Group plc a été divulguée. Investissement Financier Groupe Vanguard Divulgation Des Actions Groupe Greencore Code Des OPA Britannique
BRIEF published on 11/26/2025 at 15:16, 11 months 26 days ago Final Offer Price Notification for ISIN XS2999242469 Final Offer Price AMF Approval Prospectus Regulation BNP Paribas Issuance ISIN XS2999242469
BRIEF published on 11/26/2025 at 15:16, 11 months 26 days ago Avis de prix final pour l'ISIN XS2999242469 Règlement Sur Les Prospectus Approbation AMF Prix De L'offre Finale Émission De BNP Paribas ISIN XS2999242469
BRIEF published on 11/26/2025 at 15:05, 11 months 26 days ago Aspire Biopharma Strengthens Team with New Appointment Sublingual Delivery Aspire Biopharma Dr. Mark J. Jaroszeski DNA/drug Innovation Scientific Team
BRIEF published on 11/26/2025 at 15:05, 11 months 26 days ago Aspire Biopharma renforce son équipe avec une nouvelle nomination Administration Sublinguale Aspire Biopharma Dr Mark J. Jaroszeski Innovation ADN/médicament Équipe Scientifique
Published on 11/20/2026 at 15:00, 2 days 2 hours ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 2 days 2 hours ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 2 days 3 hours ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 2 days 4 hours ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 2 days 4 hours ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 23:45, 1 day 17 hours ago APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Published on 11/20/2026 at 22:39, 1 day 18 hours ago ABIVAX: Abivax publie une déclaration concernant le rapport d'un vendeur à découvert
Published on 11/20/2026 at 21:36, 1 day 20 hours ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 20:49, 1 day 20 hours ago E-PANGO: Jugement du Tribunal Judiciaire de Paris relatif au contentieux avec le groupement RIVP-HENEO-HSF
Published on 11/20/2026 at 18:34, 1 day 23 hours ago Déclaration hebdomadaire d'opérations effectuées du 16 au 20 novembre 2026
Published on 11/20/2026 at 18:34, 1 day 23 hours ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 2 days ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 16 au 20 novembre 2026
Published on 11/20/2026 at 17:35, 2 days ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 2 days 22 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR